Boston Microfluidics

Learn how BMF is developing at-home serologic testing for COVID-19

A new era for blood collection and testing.

*BMF is customizing sample collection kits for our industry partners. Kits are not available under the BMF brand.

Buy

Order a collection kit (typically arrives within 2-3 days).

Collect

Mail

Mail the sample using the pre-paid postage label.

Get Results

Get results online within 3-5 days.

About Us

Boston Microfluidics develops simple and intuitive blood collection devices designed to greatly simplify and revolutionize blood testing globally. Our mission is to design devices that make it easier for people, and their healthcare providers, to connect to their health, while reducing the barriers that prevent people from getting blood tests.

Our Technology

The Neotainer™ – our flagship product co-developed with LabCorp – was designed with both the consumer and lab operator in mind. The device is designed to allow anyone, anywhere to collect high quality samples without a phlebotomist. Self-collection is simple, intuitive, and needle free. the blood samples can be seamlessly delivered through US mail from the consumer to the lab ready to go to the lab’s standard analyzers.

If you are a commercial entity and would like to request a sample kit, please contact us.

Now Available

A version of our latest testing kit is available today with Pixel by LabCorp. A self-sample collection kit can be requested online. All requests are reviewed by a physician before being fulfilled and shipped to any location within the United States except New York, New Jersey, Rhode Island and Maryland. Samples collected are shipped to and processed by LabCorp.

Boston Microfluidics Appoints Linh Hoang, MD, PhD as CEO

June 8, 2020

CAMBRIDGE, Mass., June 8, 2020 – Boston Microfluidics (BMF), a developer of simple, intuitive blood collection devices, today announced that it has appointed Linh Hoang, MD, PhD, as its new

Boston Microfluidics Raises $17.5M in Series A Funding Round

August 26, 2019

CAMBRIDGE, Mass., August 27, 2019 – Boston Microfluidics (BMF), a developer of simple, intuitive blood collection devices, today announced it has raised $17.5 million in new funding. The Series A